文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

aroD基因缺失使福氏志贺菌2457T菌株减毒,并使其成为一种对猴子安全有效的口服疫苗。

AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.

作者信息

Kärnell A, Cam P D, Verma N, Lindberg A A

机构信息

Karolinska Institute, Department of Clinical Bacteriology, Huddinge Hospital, Sweden.

出版信息

Vaccine. 1993;11(8):830-6. doi: 10.1016/0264-410x(93)90358-5.


DOI:10.1016/0264-410x(93)90358-5
PMID:8356844
Abstract

The aromatic-dependent live Shigella flexneri 2a vaccine strain SFL1070, with a deleted aroD gene, had a much reduced intracellular growth in HeLa cells compared with its parent strain S. flexneri 2457T. S. flexneri SFL1070 gave no adverse effects in eight Macaca fascicularis monkeys orally vaccinated with four doses of 1 x 10(11) live bacteria within a 5-week period, whereas S. flexneri 2457T caused dysentery in all eight non-vaccinated monkeys. Thus the aromatic dependency rendered S. flexneri SFL1070 significantly attenuated (p = 0.00008). Significant intestinal S. flexneri lipopolysaccharide (LPS)-specific sIgA responses were seen in seven of eight vaccinated monkeys (p < 0.01) after four doses with SFL1070. However, serum IgG or IgA responses to various S. flexneri LPS antigens and the invasion plasmid antigens (Ipa-s) were seen in only four of eight vaccinated monkeys. The serum IgG titre increases against S. flexneri Y and 2a LPS reached significant levels (p < or = 0.05). All but one of the vaccinated monkeys were protected against oral challenge with 1 x 10(10) or 1 x 10(11) live S. flexneri 2457T given 2 weeks after the last vaccination. The protection was highly significant (p = 0.0007) as all non-vaccinated monkeys challenged with equal doses of strain 2457T developed dysentery. Three of them succumbed. Challenge infection of vaccinated monkeys elicited serum IgA and IgG responses to the homologous S. flexneri 2a LPS in three monkeys each (0.005 < or = p < or = 0.025). Serum IgA and IgG responses to the Ipa-s were seen in five and four monkeys each (0.01 < p < or = 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

依赖芳香族氨基酸的福氏志贺菌2a活疫苗株SFL1070缺失aroD基因,与亲本菌株福氏志贺菌2457T相比,其在HeLa细胞内的生长显著减少。在5周内给8只食蟹猴口服接种四剂1×10¹¹个活细菌,福氏志贺菌SFL1070未产生不良反应,而福氏志贺菌2457T在所有8只未接种的猴子中均引起痢疾。因此,芳香族氨基酸依赖性使福氏志贺菌SFL1070显著减毒(p = 0.00008)。在8只接种疫苗的猴子中有7只(p < 0.01)在用SFL1070接种四剂后出现了显著的肠道福氏志贺菌脂多糖(LPS)特异性分泌型IgA反应。然而,在8只接种疫苗的猴子中只有4只出现了针对各种福氏志贺菌LPS抗原和侵袭质粒抗原(Ipa-s)的血清IgG或IgA反应。针对福氏志贺菌Y和2a LPS的血清IgG滴度升高达到显著水平(p ≤ 0.05)。在最后一次接种后2周,除1只猴子外,所有接种疫苗的猴子均受到保护,免受1×10¹⁰或1×10¹¹个福氏志贺菌2457T活菌的口服攻击。这种保护作用非常显著(p = 0.0007),因为所有接受等量2457T菌株攻击的未接种猴子均出现痢疾。其中3只死亡。对接种疫苗的猴子进行攻击感染后,3只猴子各自出现了针对同源福氏志贺菌2a LPS的血清IgA和IgG反应(0.005 ≤ p ≤ 0.025)。分别在5只和4只猴子中观察到针对Ipa-s的血清IgA和IgG反应(0.01 < p ≤ 0.05)。(摘要截断于250字)

相似文献

[1]
AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.

Vaccine. 1993

[2]
Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers.

Vaccine. 1995-1

[3]
Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes.

Vaccine. 1992

[4]
Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: characterization and monkey protection studies.

Vaccine. 1992

[5]
Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in adult Vietnamese volunteers.

Vaccine. 1993

[6]
An auxotrophic live oral Shigella flexneri vaccine: development and testing.

Rev Infect Dis. 1991

[7]
Development of an auxotrophic oral live Shigella flexneri vaccine.

Vaccine. 1988-4

[8]
Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in volunteers.

Vaccine. 1992

[9]
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection.

EBioMedicine. 2021-4

[10]
Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.

Vaccine. 1999-8-6

引用本文的文献

[1]
Quinate-based ligands for irreversible inactivation of the bacterial virulence factor DHQ1 enzyme-A molecular insight.

Front Mol Biosci. 2023-1-24

[2]
Development of an Aotus nancymaae model for Shigella Vaccine immunogenicity and efficacy studies.

Infect Immun. 2014-3-4

[3]
Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations.

APMIS. 2013-9-13

[4]
Systematic annotation and analysis of "virmugens"-virulence factors whose mutants can be used as live attenuated vaccines.

Vaccine. 2012-12-6

[5]
Questions about the behaviour of bacterial pathogens in vivo.

Philos Trans R Soc Lond B Biol Sci. 2000-5-29

[6]
A riboflavin auxotroph of Actinobacillus pleuropneumoniae is attenuated in swine.

Infect Immun. 1996-11

[7]
Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.

Infect Immun. 1994-11

[8]
The epidemiology of Haemophilus influenzae type b disease in the Republic of Ireland.

Epidemiol Infect. 1995-6

[9]
Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes.

J Bacteriol. 1995-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索